chr8-11771508-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145043.4(NEIL2):āc.61C>Gā(p.Gln21Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000737 in 1,614,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_145043.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NEIL2 | NM_145043.4 | c.61C>G | p.Gln21Glu | missense_variant | 2/5 | ENST00000284503.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NEIL2 | ENST00000284503.7 | c.61C>G | p.Gln21Glu | missense_variant | 2/5 | 2 | NM_145043.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000414 AC: 63AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000111 AC: 28AN: 251472Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135912
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1461838Hom.: 0 Cov.: 31 AF XY: 0.0000371 AC XY: 27AN XY: 727220
GnomAD4 genome AF: 0.000414 AC: 63AN: 152294Hom.: 0 Cov.: 32 AF XY: 0.000376 AC XY: 28AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2023 | The c.61C>G (p.Q21E) alteration is located in exon 2 (coding exon 1) of the NEIL2 gene. This alteration results from a C to G substitution at nucleotide position 61, causing the glutamine (Q) at amino acid position 21 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at